COVID-19 Market Darlings in the US: DDOG, NOW, TDOC

Yes, coronavirus has indeed caused havoc for most of the stocks in the market. But some are still shining bright, as their business model appears to be exhibiting resilience amid the pandemic. One has to carefully look at how the business is generating revenues and impacts the flow of revenues among other measures.

Ironically, these three stocks are currently trading around lifetime high-levels, which speaks volume why these are COVID-19 market darlings at the moment.

Let’s discuss these three businesses:

Datadog, Inc. (NASDAQ:DDOG)

Datadog, Inc. provides surveillance and analytics platform to the information technology teams of the business in the cloud world. Its services are used by organisations irrespective of their size across various industries. DDOG enables cloud migration, digital transformation, collaborations, and operational efficiency.

Revenue Growth of 87% for DDOG in Q1

Earlier this month, the Company reported first quarter results for the period ended 31 March 2020. In Q1, Datadog recorded revenue growth of 87% over the same quarter last fiscal year and delivered a new product as well.

At the end of the period, DDOG customer count with annualised recurring revenue of above $100k was 960, up by 89% from 508 against the same period last year. Security Monitoring product was launched by the Company, providing operational resilience to the businesses.

The Company also released integration for customers with Amazon Managed Streaming, including ClickHouse, Hashicorp Vault, VMware Carbon Black, Apache Kafka, Apache Airflow, and AWS Step Function. DDOG continues to refine all existing integrations while also adding the new ones.

Meanwhile, the Company continues to innovate new products as well as existing products. During the period, DDOG added new features to auto-detection engine – Watchdog, which is based on machine learning. Besides, the Company extended Net Performance Monitoring and achieved the AWS Lambda Ready designation.

Revenue during Q1 was $131.2 million. The Company achieved GAAP-based operating income of $3.8 million and net income per diluted share stood at $0.06. Operating cash flow for the period was $24.3 million with a free cash flow of $19.3 million. At the end of period, the Company had cash and cash equivalents of $798.5 million. In FY20, Datadog is expecting a revenue between $555 million and $565 million and non-GAAP based operating income in the range of $0 million to $10 million.

On 21 May 2020, DDOG last traded at $69.89, down by 1.15% from the previous close.

ServiceNow, Inc. (NYSE:NOW)

ServiceNow, Inc. was incorporated as Glidesoft, Inc. in California, UA. It serves to a wide range of industries, including Government, telecommunications, financial services, manufacturing, consumer products, information technology, oil & gas, and healthcare. The Company’s flagship platform automates workflows across functions in an organisation.

Four-App Based Dashboard Launched

Recently, NOW released a four-app based dashboard for organisations to manage necessary steps, as they embrace re-openings and employees return back to workplaces. The new product would allow its customers to manage health and safety of the employees.

Source: Servicenow website

ServiceNow Safe Workplace pack addresses areas related to employee eligibility, health screening, safety management and PPE inventory management. Based on the responses by an employee, the application provides employees preparedness. Screening application allows the organisation to ensure employees are not having any illness when coming to work.

Safety management application would enable managers to ascertain the safety levels by applying measures such as social distancing via split shifts and more. PPE inventory management application will monitor the PPE needs of a business.

Q1 Subscription Revenues Up 34%

In late-April 2020, the Company reported first quarter results for the period ended 31 March 2020. Its subscription revenues for the period were $995 million, up by 34% against the same period last fiscal year.

In Q1, the business completed 37 new transactions having over $1 million in annual contract value (ACV), indicating an increase of 48% over the year. At the end of period, it had 933 total customers with over $1 million in ACV, growing by 30% over the same period last year.

On GAAP basis, NOW delivered total revenue of $1.04 billion for the period with total gross profit of $823 million. Its net income for the period was $48 million, equating to diluted earnings per share of $0.24.

Management believes that the business is in a strong position to weather the shock of COVID-19, but many of its customers are operating in a challenging environment that may trigger a reassessment of spending.

Therefore, they have updated the guidance for the full year as well as second quarter, assuming that most of the impact on its customers would be visible in the second and third quarter of the year. Management team also assumes that economic conditions will resume broadly by the end of the year and that there will be uncertainty from the businesses in most affected areas.

Moreover, they are expecting subscription revenues between $995 million to $1 billion in the second quarter and in between $4,125 million and $4,145 million for the full year.

On 21 May 2020, NOW last traded at $383.64, down by 1.67% from the previous close.

Teladoc Health, Inc. (NYSE:TDOC)

Teladoc Health, Inc. is a virtual provider of telehealth services. Its virtual healthcare services incorporate a large number of medical subspecialties, including flu, chronic medical conditions, non-urgent, cancer, congestive heart failure, and respiratory infections. The Company provides services to businesses as well as consumers. Some of its consumer brands include Best Doctors, BetterHelp, Healthiest You, Advance Medical and Teladoc.

Convertible Senior Notes Worth $850 Million Priced

Last week, the Company priced Convertible Senior Notes worth $850 million (aggregate principal) maturing in 2027. It was conducted through a private QIB issue, and net proceeds would be around $829 million.

TDOC would use a portion of raised money to exchange its Convertible Notes Due 2022 with cash and shares. These notes have a principal amount of approximately $228.2 million, where the Company would pay ~$231.1 million in cash and 3.9 million in shares.

Its new notes due in 2027 have an interest rate of 1.25% per annum. The remaining proceeds would be utilised for general corporate purposes, working capital, merger and acquisition opportunities, and repayment of other obligations.

Q1 Total Revenue Up 41%

In late-April, the Company reported first quarter results for the period ended 31 March 2020. During the quarter, the business conducted 2 million medical visits across its markets, generating a total revenue of $180.8 million, up by 41% from $128.5 million in the previous year.

Net loss for the period was $29.6 million compared to $30.2 million in the same period last year, and EBITDA for the period was -$11.3 million against -$13.3 million in 1Q19. In Q2, the Company’s revenue target is between $215 million and $225 million, while it is $800 million to $825 million for the full year.

On 21 May 2020, TDOC last traded at $174.99, up by 2.17% from the previous close.

Do Read: Coronavirus: The Grey Or Black Swan?

(All currencies in USD unless or otherwise stated)


Disclaimer
The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK